Physician

Benjamin Charles Chasnis, M.D.

According to 2025 Medicare claims, Benjamin Chasnis, M.D. (NPI: 1760436422) practices physical medicine and rehabilitation in the Burlington, NC market, with the plurality of this provider's patient population coming from Alamance, NC. This provider's primary affiliated billing organization is DUKE HEALTH INTEGRATED PRACTICE, INC. (NPI: 1205553369; TIN: 862109896) and primary practice location at 27215-8700. Chasnis is affiliated with the Duke Connected Care, LLC (ACO ID: A2419) and Triad HealthCare Network, LLC. (ACO ID: D0209), participating under both the MSSP and REACH models.

Chasnis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 227 traditional Medicare patients, billed 5,175 HCPCS/CPT codes, and received $117,508 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 1,128 prescription claims across 215 beneficiaries totaling $16,027 in drug costs, led by Gabapentin (Gabapentin). 2018 DME data shows 20 claims. Open Payments data shows 1 records totaling $96. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $118,216 to $16,027. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	400	7,545	$129,166
2016	431	8,445	$139,654
2017	399	8,058	$129,789
2018	388	8,314	$133,590
2019	355	9,602	$144,254
2020	297	7,271	$123,077
2021	284	7,890	$160,093
2022	248	5,146	$115,244
2023	246	4,932	$115,825
2024	227	5,175	$117,508

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	478	2,803	$118,216
2016	477	2,779	$94,499
2017	453	2,623	$70,540
2018	415	2,623	$80,599
2019	340	1,564	$41,320
2020	315	1,422	$32,545
2021	308	1,317	$30,746
2022	340	1,600	$31,397
2023	255	1,164	$17,351
2024	215	1,128	$16,027

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	20	$614
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	150	231	$194
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	56	122	$87
64484	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level	69	101	$80
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	184	1,314	$0
J1100	Injection, dexamethasone sodium phosphate, 1 mg	173	2,732	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gabapentin	Gabapentin	254	12,229	$4,190
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	235	5,934	$4,045
Tramadol Hcl	Tramadol Hcl	235	5,654	$1,752
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	69	1,893	$1,495
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	1,451	$567

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$96	SPR Therapeutics, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Benjamin Charles Chasnis, M.D.?

Tedicare shows public-source Medicare data for Benjamin Charles Chasnis, M.D. (NPI 1760436422), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Benjamin Charles Chasnis, M.D. have ACO affiliation data?

Benjamin Charles Chasnis, M.D. is shown with ACO affiliation data for Duke Connected Care, LLC (MSSP, ACO ID A2419) and Triad HealthCare Network, LLC. (REACH, ACO ID D0209).

What billing organization is linked to Benjamin Charles Chasnis, M.D.?

Benjamin Charles Chasnis, M.D. is linked to DUKE HEALTH INTEGRATED PRACTICE, INC. (billing NPI 1205553369) in the available physician profile data.

Does Benjamin Charles Chasnis, M.D. have Open Payments data?

Benjamin Charles Chasnis, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.